Notice of Intent to Sole Source-Evaluating the Effect of Obesity on the Pharmacokinetics and Pharmacodynamics
Closed Special Notice Posted
- Solicitation number
- FDA6182024
- Agency
-
FDA Office of Acquisition and Grant Services
Food and Drug Administration, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- PSC
- AJ11 General Science And Technology R&D Services; General Science And Technology; Basic Research
- Place of performance
- United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Food and Drug Administration (FDA) has issued a Special Notice to award a Sole Source Firm Fixed Price contract order to the University of North Carolina at Chapel Hill. This contract order is for the purpose of evaluating the effect of obesity on the pharmacokinetics and pharmacodynamics.
The purpose of this Special Notice is to inform the public of the FDA's intent to issue a Firm Fixed Price contract to the University of North Carolina at Chapel Hill. The minimum requirements are outlined in the attached Statement of Work. While this is not a request for competitive proposals, any party that believes it can meet the requirements may submit a written capability statement demonstrating their ability to perform the work. The capability statements must be received by June 25, 2024, at 3:00 PM EST. The FDA will review the submissions to determine if any other organization has the capability to meet the requirement. If no other qualified organizations are identified, the contract will be awarded to the University of North Carolina at Chapel Hill within approximately ten days after the date of this notice.
Notice text
The Food and Drug Administration (FDA) intends to award a Sole Source Firm Fixed Price contract order to University of North Carolina at Chapel Hill, 301 Pharmacy Lane, CB 7355, Chapel Hill, NC 27599-7355.
In accordance with FAR Part 6.302-1 (a) (2)(ii) which states” Only one responsible source and no other supplies or services will satisfy agency requirement”.
The purpose of this notice is to inform the public that the Food and Drug Administration (FDA) anticipates issuing a Firm Fixed Price contract.
MINIMUMREQUIREMENTS:
See Attached Statement of Work
This notice is not a request for competitive proposals. However, any party that believes it can meet this requirement as stated herein may submit a written capability statement that clearly supports and demonstrates their ability to perform the requirement.
Capability statements must be received by the response date and time of this notice. Submissions will be reviewed to determine if they can meet the requirement. A determination by the Government to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government.
It is anticipated that an award will be issued to University of North Carolina at Capital Hill within approximately ten (10) days after the date of this notice unless the Government determines that any other organization has the capability to meet this requirement.
Response Date: June 25, 2024, by 3.00PM EST. Please email responses to Hilda Aryeh –hilda.aryeh@fda.hhs.gov.
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity